Filter
2128
Text search:
КОВИД-19
Featured
236
4
Language
Document type
623
306
287
244
123
114
112
111
71
53
30
28
22
3
1
Countries
238
197
183
144
133
124
103
97
90
86
85
81
79
75
73
67
67
48
47
46
44
42
42
39
37
32
30
29
29
28
27
26
25
24
23
23
22
22
22
21
21
20
20
18
17
17
16
16
16
15
14
14
13
12
12
12
12
12
12
11
11
11
10
10
10
10
9
9
9
9
9
8
8
8
8
8
8
8
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
2120
41
27
16
16
14
8
Toolboxes
1919
40
24
9
8
8
5
4
3
2
2
2
2
2
1
1
1
1
1
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppe sowie zu Wechselwirkungen und Nebenwirkungen.
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppen sowie zu Wechselwirkungen und Nebenwirkungen von Impfstoffen und Arzneimitteln zu COVID-19 und SARS-CoV-2
This website has been created to provide accurate and up-to-date information about Sputnik V.
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h
...
11/05/2020
Prevenir a contaminação de superfícies e manter condições adequadas de limpeza e desinfecção nos espaços públicos é fundamental para mitigar a transmissão do vírus e proteger a saúde dos trabalhadores e do público em geral. As superfícies com alta frequência de contato (m
...
Recomendações gerais: • Colocar o paciente em um quarto individual bem ventilado (com as janelas abertas). • Limitar o movimento do paciente pela casa e minimizar o espaço a ser compartilhado. Certificar-se de que os espaços compartilhados estejam bem ventilados. • Separar os espaços para
...
Navegue pelos dados do Sistema Único de Saúde - SUS, com informações estratégicas e conheça tudo sobre a COVID-19 de forma transparente e analítica
Nota INformatIva Nº 13/2020 - SE/GaB/SE/mS
September 2020
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
January 2021. Save the Children urges governments and donors to take five urgent steps to ensure that children who were in school prior to COVID-19 closures can safely return:
Financial support for the world’s poorest families, so they can send their children to school and keep them healthy;
...
Material in multiple languages
CANVax is the first online database of its kind in Canada to support immunization program planning and promotional activities to improve vaccine acceptance and uptake in Canada. CANVax houses a collection of curated evidence based products and resources to make it eas
...
COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT2), developed by WHO-PAHO, UNICEF, World Bank, Gavi, and other partners is a tool to help prepare countries for the introduction a COVID-19 vaccine.
It provides a roadmap for introduction and a structured framework for countries to self-
...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their
...
Africa Medical Supply Platform
recommended
AMSP opens COVID-19 vaccines pre-orders for 55 African Union Member States
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
Updated 28 December 2020
